Jane Novak - CF Acquisition Chief Officer
CFFSU Stock | USD 11.07 0.00 0.00% |
Insider
Jane Novak is Chief Officer of CF Acquisition VII
Age | 59 |
Address | 110 East 59th Street, New York, NY, United States, 10022 |
Phone | 212-938-5000 |
Jane Novak Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jane Novak against CF Acquisition stock is an integral part of due diligence when investing in CF Acquisition. Jane Novak insider activity provides valuable insight into whether CF Acquisition is net buyers or sellers over its current business cycle. Note, CF Acquisition insiders must abide by specific rules, including filing SEC forms every time they buy or sell CF Acquisition'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jane Novak over six months ago Insider Trading |
CF Acquisition Management Efficiency
At this time, CF Acquisition's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.02 in 2024, whereas Return On Capital Employed is likely to drop (0.01) in 2024. Total Current Liabilities is likely to drop to about 5.3 M in 2024. Liabilities And Stockholders Equity is likely to drop to about 146.1 M in 2024CF Acquisition's management efficiency ratios could be used to measure how well CF Acquisition manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Ann Challis | Goosehead Insurance | N/A | |
Leslie Wojcik | SEI Investments | N/A | |
Jose Teixeira | Patria Latin American | 45 | |
James Smigiel | SEI Investments | 55 | |
Raquel Lizarraga | ABIVAX Socit Anonyme | N/A | |
Julia Jordan | Goosehead Insurance | N/A | |
Regina Jehle | ABIVAX Socit Anonyme | N/A | |
Pierre MBA | ABIVAX Socit Anonyme | N/A | |
Jared Sinclair | Goosehead Insurance | N/A | |
Paul Gineste | ABIVAX Socit Anonyme | N/A | |
Philippe MD | ABIVAX Socit Anonyme | 65 | |
Patrick Langston | Goosehead Insurance | 42 | |
Alain Chevallier | ABIVAX Socit Anonyme | 70 | |
Joe McCabe | SEI Investments | N/A | |
Marco DIppolito | Patria Latin American | 47 | |
Prof Ehrlich | ABIVAX Socit Anonyme | N/A | |
Anne Pascard | ABIVAX Socit Anonyme | N/A |
Management Performance
Return On Asset | -0.0086 |
CF Acquisition VII Leadership Team
Elected by the shareholders, the CF Acquisition's board of directors comprises two types of representatives: CF Acquisition inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CFFSU. The board's role is to monitor CF Acquisition's management team and ensure that shareholders' interests are well served. CF Acquisition's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CF Acquisition's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jane Novak, Chief Officer | ||
Howard Lutnick, Chairman CEO |
CFFSU Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CF Acquisition a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -0.0086 | ||||
Current Valuation | 124.35 M | ||||
Shares Owned By Institutions | 0.11 % | ||||
EBITDA | 5.97 M | ||||
Net Income | 2.91 M | ||||
Cash And Equivalents | 106.13 K | ||||
Total Debt | 8.46 M | ||||
Current Ratio | 0.17 X | ||||
Book Value Per Share | (0.48) X | ||||
Cash Flow From Operations | 2.91 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CFFSU Stock Analysis
When running CF Acquisition's price analysis, check to measure CF Acquisition's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CF Acquisition is operating at the current time. Most of CF Acquisition's value examination focuses on studying past and present price action to predict the probability of CF Acquisition's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CF Acquisition's price. Additionally, you may evaluate how the addition of CF Acquisition to your portfolios can decrease your overall portfolio volatility.